SENTIA: an intensive medicines monitoring programme for proactive safety surveillance of neuroleptic treatment in children and adolescents

被引：0
|
作者：
Palanca Maresca, Inmaculada [1 ]
Ruiz-Antoran, Belen [2 ]
Olza-Fernandez, Ibone [1 ]
Siles, Ana [3 ]
Villagra, Sandra [3 ]
Fernandez Rivas, Aranzazu [4 ]
Garcia Vega, Juan Manuel [1 ]
Centeno, Gustavo [2 ]
Roman, Enriqueta [5 ]
Avendano-Sola, Cristina [2 ]
机构：
[1] Univ Puerta de Hierro, Majadahonda Hosp, Child & Adolescent Psychiat Unit, Madrid, Spain
[2] Univ Puerta de Hierro, Majadahonda Hosp, Dept Clin Pharmacol, Madrid, Spain
[3] Univ Puerta de Hierro, Majadahonda Hosp, Paediat Cardiol Unit, Madrid, Spain
[4] Basurto Hosp, Child & Adolescent Psychiat Unit, Bilbao, Spain
[5] Univ Puerta de Hierro, Majadahonda Hosp, Paediat Serv, Madrid, Spain
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2013年 / 22卷
关键词：
Antipsychotic; adverse effects; pharmacovigilance registry; paediatric populations;
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
PS-046
引用
收藏
页码：S230 / S231
页数：2
相关论文
共 50 条
  • [31] The Role of the New Zealand Intensive Medicines Monitoring Programme in Identification of Previously Unrecognised Signals of Adverse Drug Reactions
    Clark, David W. J.
    Harrison-Woolrych, Mira
    CURRENT DRUG SAFETY, 2006, 1 (02) : 169 - 178
  • [32] Outcomes of a non-operative caries treatment programme for children and adolescents
    Ekstrand, KR
    Christiansen, MEC
    CARIES RESEARCH, 2005, 39 (06) : 455 - 467
  • [33] Safety profile of atomoxetine in the treatment of children and adolescents with ADHD
    Wernicke, JF
    Kratochvil, CJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 50 - 55
  • [34] Efficacy and safety of antidepressant drug treatment in children and adolescents
    Henry, A.
    Kisicki, M. D.
    Varley, C.
    MOLECULAR PSYCHIATRY, 2012, 17 (12) : 1186 - 1193
  • [35] Efficacy and safety of antidepressant drug treatment in children and adolescents
    A Henry
    M D Kisicki
    C Varley
    Molecular Psychiatry, 2012, 17 : 1186 - 1193
  • [36] The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand
    Tatley, Michael V.
    Kunac, Desiree L.
    McNicholas, Anne
    Zhou, Lifeng
    Ballantyne, Suzie
    Ashton, Janelle
    Stehr-Green, Paul
    Galloway, Yvonne
    Reid, Stewart
    VACCINE, 2008, 26 (22) : 2746 - 2752
  • [37] THE INTENSIVE SAFETY SURVEILLANCE SCHEME (IS3) MIGLUSTAT POST-MARKETING SURVEILLANCE (PMS) PROGRAMME: RATIONALE, DESIGN AND PATIENT CHARACTERISTICS
    Rolfs, A.
    Belmatoug, N.
    Hollak, C.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 170 - 170
  • [38] Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders
    Bourke, JP
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (03): : 164 - +
  • [39] COX-2 inhibitors may cause dysrrhythmias - A signal from the New Zealand intensive medicines monitoring programme
    Savage, RL
    Coulter, DM
    Harrison-Woolrych, M
    DRUG SAFETY, 2005, 28 (10) : 963 - 963
  • [40] Intensive Home Treatment of Addicted Children and Adolescents. A Qualitativ Investigation
    Moser, Florian
    SUCHTTHERAPIE, 2024,
12345